Oxidized lipids: The two faces of vascular inflammation

  title={Oxidized lipids: The two faces of vascular inflammation},
  author={Konstantin G Birukov},
  journal={Current Atherosclerosis Reports},
  • K. Birukov
  • Published 1 May 2006
  • Biology
  • Current Atherosclerosis Reports
Elevated plasma levels of low-density lipoprotein and generation of oxidized low-density lipoprotein have been directly associated with the pathogenesis of atherosclerosis, and lipid oxidation products have been directly linked with induction and propagation of monocytic subendothelial accumulation and other inflammatory reactions associated with chronic vascular inflammation. However, accumulating data suggest that oxidized lipids may also exhibit anti-inflammatory potential and serve as… 
Oxidized Phospholipids in Control of Endothelial Barrier Function: Mechanisms and Implication in Lung Injury
Signaling and cytoskeletal mechanisms involved in OxPLs-mediated damage, rescue, and restoration of endothelial barrier in various pathophysiological settings are summarized and a future potential of OxPAPC in treating lung disorders associated with endothelial Barrier dysfunction is discussed.
Lipid mediators in the regulation of endothelial barriers
The role of oxidized phospholipids in control of vascular endothelial barrier, agonist induced EC permeability, inflammation, and barrier recovery related to clinical settings of acute lung injury and inflammatory vascular leak is focused on.
Inflammatory profile of oxidized phospholipids.
The inflammatory properties of OxPL are discussed together with the underlying receptor, signalling and transcriptional mechanisms to suggest that, in addition to the proatherogenic and proinflammatory effects, OxPL can stimulate antiinflammatory and tissue-protective mechanisms.
Oxidized lipoprotein lipids and atherosclerosis
An overview of the present knowledge of lipoprotein LOP transport and its association with the risk of atherosclerosis and cardiovascular diseases (CVD) is given and the proposed lipo-specific transport function would affect conception of the etiology of Atherosclerosis, but would not conflict current views of the pathophysiological mechanisms.
Lipid Oxidation Products on Inflammation-Mediated Hypertension and Atherosclerosis: A Mini Review
This review aims to summarize the current evidence of lipid oxidation products on hypertension and atherosclerosis via inflammatory pathway, and toxic lipid oxidation Products such as malondialdehyde and 4-hydroxy-2-nonenal are taken into account.
Oxidized low-density lipoprotein.
Until its pathophysiological significance, and how it is generated in vivo are determined, the nature of its true identity will be only of classical interest.
Mediators of Vascular Inflammation
Recent advances in the understanding of the mechanisms of vascular inflammation are described, showing that vascular inflammation can be limited by anti-inflammatory counter regulatory mechanisms that maintain the integrity and homeostasis of the vascular wall.


Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries
Oxidized phospholipids contribute to vascular inflammation in murine arteries in vivo, initiating atherogenic chemokine expression that leads to monocyte adhesion; therefore, they can be regarded as triggers of the inflammatory process in atherosclerosis.
Oxidized phospholipids as modulators of inflammation in atherosclerosis
  • N. Leitinger
  • Biology, Chemistry
    Current opinion in lipidology
  • 2003
During inflammatory processes biologically active lipid oxidation products accumulate that modulate the inflammatory process and may determine the fate and outcome of the body's reaction in acute inflammation during host defense.
Role of oxidative modifications in atherosclerosis.
An "oxidative response to inflammation" model is proposed as a means of reconciling the response-to-injury and oxidative modification hypotheses of atherosclerosis.
Oxidized phospholipids as triggers of inflammation in atherosclerosis.
This review will address important questions regarding mechanisms involved in acute and chronic inflammation, and discuss the role of OxPL as key players in triggering the inflammatory response in atherosclerosis.
Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis.
It has been demonstrated that 5-lipoxygenase localized in macrophages generates leukotrienes, which exhibit strong proinflammatory activities in cardiovascular tissues and contribute to lesion development, and the inhibition of these lipoxygenases may be effective in the prevention and treatment of the inflammatory diseases.
Anti-inflammatory properties of lipid oxidation products
This contribution summarizes recent findings on the anti-inflammatory action of oxidized lipoproteins and lipid oxidation products and discusses confirmed and suggested mechanisms as well as the (patho)physiological significance of these findings.
Phospholipid mediators in the vessel wall: involvement in atherosclerosis
  • E. Ninio
  • Biology, Chemistry
    Current opinion in clinical nutrition and metabolic care
  • 2005
Phospholipid-borne mediators are certainly key players in inflammation and thus in atherosclerosis, with the emphasis on platelet-activating factor and its analogues generated upon the oxidation of lipoproteins in vascular pathology, including atherogenesis.
Structural Identification of a Novel Pro-inflammatory Epoxyisoprostane Phospholipid in Mildly Oxidized Low Density Lipoprotein*
The fragmentation pattern produced by electrospray ionization-collision induced dissociation-tandem mass spectrometry was consistent with a molecule resembling an E-ring prostaglandin with an epoxide at the 5,6 position, adding epoxyisoprostane E2 to the growing list of biologically active isoprostanes.
Identification of genes induced by oxidized phospholipids in human aortic endothelial cells.